Home Keryx says anemia drug succeeds in study of kidney patients
 

Keywords :   


Keryx says anemia drug succeeds in study of kidney patients

2016-03-29 13:57:33| Biotech - Topix.net

Keryx Biopharmaceuticals Inc on Tuesday said its drug to treat iron deficiency anemia in chronic kidney disease patients not yet requiring dialysis met the goals of a late stage clinical trial, potentially paving the way for an expanded approval of the treatment. In the 16-week study of 234 patients with moderate to severe kidney disease, 52 percent of those who received Keryx's ferric citrate saw their hemoglobin levels rise by at least 1 gram per deciliter of blood during the trial.

Tags: study drug patients kidney

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11
23.11ProjectDIVAF
23.11MtG
23.11THUNDER TRUCKS HOLLOW II 148
23.11 the Tiger 7 EP
23.11 11 LEGACY
23.11 GENOCIDE
23.11HG PART1 PART2
More »